TPG Backs JCR Pharma

TPG Biotech has entered into an agreement with Japan-based JCR Pharmaceuticals Co., to fund late-stage clinical development of two JCR drug candidates. No financial terms were disclosed. 

PRESS RELEASE 

TPG Biotech and JCR Pharmaceuticals Co., Ltd. of Ashiya, Japan jointly announced that they have entered into an Investment Agreement to fund the late-stage clinical development of two promising drug candidates for  JCR,  JR-013 and Growject